RNAC vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

RNAC

45.5
AI Score
VS
JBIO Wins

JBIO

48.9
AI Score

Investment Advisor Scores

RNAC

46score
Recommendation
HOLD

JBIO

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RNAC JBIO Winner
Net Income -130.30M -96.13M JBIO
Operating Income -143.41M -102.36M JBIO
ROE 103.2% -21.9% RNAC
ROA -44.0% -20.4% JBIO
Total Assets 296.41M 472.11M JBIO
Cash 125.14M 107.25M RNAC
Current Ratio 8.65 14.93 JBIO
Free Cash Flow -79.39M -67.93M JBIO

Relative Price Performance (Last 90 Days)

RNAC 1M: -5.6% · 3M: +1.6% JBIO 1M: -22.9% · 3M: +11.3%

Current Technical Phase

RNAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $8.19

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 31.1 · Price: $17.89

Fundamentals Snapshot

Metric RNAC JBIO
Market Cap
Forward P/E -2.2 -6.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.9% 0.0%
Gross Margin -45.3%
Operating Margin -66.8% 0.0%
EPS -5.61 -1.07
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.